{"transactions":[{"id":3901706,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-06-07T19:29:24.000Z","date":"2018-05-31","kind":"exercise","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the the grant commencing of February 7, 2018. Vesting was accelerated to May 31, 2018 pursuant to the Company's Executive Severance and Change In Control Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the the grant commencing of February 7, 2018. Vesting was accelerated to May 31, 2018 pursuant to the Company's Executive Severance and Change In Control Policy."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the the grant commencing of February 7, 2018. Vesting was accelerated to May 31, 2018 pursuant to the Company's Executive Severance and Change In Control Policy."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the the grant commencing of February 7, 2018. Vesting was accelerated to May 31, 2018 pursuant to the Company's Executive Severance and Change In Control Policy."}],"balance_after":3333,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001209191-18-036511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919118036511/doc4.xml","form_type":"4"}},{"id":3901705,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-07T19:29:24.000Z","date":"2018-05-31","kind":"exercise","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represent shares acquired upon vesting of restricted stock units (RSUs) granted to the Reporting Person on February 7, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500, 2,500, 2,499 and 2,500 shares acquired under the Company's 2015 Employee Stock Purchase Plan (ESPP) on November 15, 2016, May 15, 2017, November 15, 2017, and May 15, 2018, respectively, each in a transaction exempt under Rule 16b-3."}],"balance_after":26264,"source":{"system":"sec-edgar","filing":"0001209191-18-036511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919118036511/doc4.xml","form_type":"4"}},{"id":4070513,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-02-08T20:39:22.000Z","date":"2018-02-07","kind":"exercise","acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 7, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the grant commencing on February 7, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the grant commencing on February 7, 2018."}],"balance_after":6666,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001209191-18-008609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919118008609/doc4.xml","form_type":"4"}},{"id":4070512,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-02-08T20:39:22.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2018, such that this option will be fully exercisable on February 6, 2022.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":100000,"derivative":{"exercise_price":3.3,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-008609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919118008609/doc4.xml","form_type":"4"}},{"id":4070511,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-08T20:39:22.000Z","date":"2018-02-08","kind":"sale","acquired":false,"shares":1402,"price":3.4,"value":4766.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 7, 2017."}],"balance_after":1932,"source":{"system":"sec-edgar","filing":"0001209191-18-008609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919118008609/doc4.xml","form_type":"4"}},{"id":4070510,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-08T20:39:22.000Z","date":"2018-02-07","kind":"exercise","acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 7, 2017."}],"balance_after":3334,"source":{"system":"sec-edgar","filing":"0001209191-18-008609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919118008609/doc4.xml","form_type":"4"}},{"id":4459578,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Manufacturing"}}],"security":"Restricted Stock Unit","published_at":"2017-02-09T16:03:04.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units (RSUs) are scheduled to vest in three equal annual installments beginning on February 7, 2018, such that the RSUs will fully vest on February 7, 2020. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units (RSUs) are scheduled to vest in three equal annual installments beginning on February 7, 2018, such that the RSUs will fully vest on February 7, 2020. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-009043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919117009043/doc4.xml","form_type":"4"}},{"id":4459577,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Manufacturing"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2017-02-09T16:03:04.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 7, 2017, such that this option will be fully exercisable on February 7, 2021.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":35000,"derivative":{"exercise_price":3.3,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-17-009043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919117009043/doc4.xml","form_type":"4"}},{"id":4514315,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Manufacturing"}}],"security":"Common Stock","published_at":"2016-12-21T18:37:14.000Z","date":"2016-12-20","kind":"purchase","acquired":true,"shares":11000,"price":2.2499,"value":24748.9,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001209191-16-156372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919116156372/doc4.xml","form_type":"4"}},{"id":4602624,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":165923,"kind":"person","name":"Amanullah Ashraf","position":1,"cik":"0001670631","reported_name":"Amanullah Ashraf","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Manufacturing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-15T18:57:09.000Z","date":"2016-09-13","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning October 13, 2016, such that this option will be fully exercisable on September 13, 2020.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":28000,"derivative":{"exercise_price":3.06,"expiration_date":"2026-09-13","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001209191-16-141655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670631/000120919116141655/doc4.xml","form_type":"4"}}]}